Recordati Stock (OTC:RCDTF), Trade Ideas

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

RECORDATI INDUSTRIA CHIM by Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati SpA

Recordati GAAP EPS of €0.59, revenue of €551.4M

Recordati Industria Chimica e Farmaceutica S.p.A. 2023 Q1 - Results - Earnings Call Presentation